drugset / Trial / NCT02236234

Immune Response to HPV Vaccine Among HIV-1-infected Subjects in Brazil

NCT02236234

Phase 4 Completed 30 enrolled University of Sao Paulo
NaSingle-groupOpen-labelPrevention

Summary

Besides the specific response to vaccine antigens, the investigators will analyze the anti-HPV immune response in HIV-1-infected men in different strata of immune deficiency. The hypothesis will be tested by stratification by T CD4 + lymphocytes in an attempt to assess the range of the count with the highest possibility of vaccine response. Thus, knowledge of vaccine response in HIV-infected patients, indicate which patients would have greater potential for vaccine response in vivo.

Timeline

Start
2012-01
Primary completion
2013-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Gardasil Vaccine

Indications